» Authors » Margaret M Cortese

Margaret M Cortese

Explore the profile of Margaret M Cortese including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 95
Citations 2619
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zalot M, Cortese M, OCallaghan K, Casey-Moore M, LEtoile N, Smart S, et al.
Pediatrics . 2024 Dec; 155(1). PMID: 39652114
Background And Objectives: Many neonatal intensive care units (NICUs) do not give rotavirus vaccines to inpatients due to a theoretical risk of horizontal transmission of vaccine strains. We aimed to...
2.
Burnett E, Riaz A, Anwari P, Myat T, Chavers T, Talat N, et al.
Vaccine . 2023 Oct; 41(48):7220-7225. PMID: 37884416
Rotavirus vaccines have substantially decreased rotavirus hospitalizations in countries where they have been implemented. In some high- and middle-income countries, a low-level of increased risk of intussusception, a type of...
3.
Satter S, Katz E, Hossain M, Fariha F, Talha M, Smart S, et al.
J Infect Dis . 2023 Aug; 229(2):457-461. PMID: 37572368
To examine the potential for respiratory transmission of rotavirus, we systematically assessed if rotavirus RNA is detectable by real-time quantitative reverse transcription-polymerase chain reaction from nasal and oropharyngeal swab specimens...
4.
Zhou Z, Cortese M, Fang J, Wood R, Hummell D, Risma K, et al.
Vaccine . 2023 May; 41(28):4183-4189. PMID: 37244808
Background: The mechanism for anaphylaxis following mRNA COVID-19 vaccination has been widely debated; understanding this serious adverse event is important for future vaccines of similar design. A mechanism proposed is...
5.
Casey-Moore M, Mijatovic-Rustempasic S, Jaimes J, Perkins C, Riley A, Cortese M, et al.
Microbiol Resour Announc . 2023 May; 12(6):e0000823. PMID: 37140434
In this study, we report the detection of a G6P[14] rotavirus strain from a human stool sample within the United States. The full genotype constellation of the G6P[14] strain was...
6.
Hesse E, Hause A, Myers T, Su J, Marquez P, Zhang B, et al.
Pediatrics . 2023 Apr; 151(5). PMID: 37082919
Background And Objectives: The Food and Drug Administration expanded Emergency Use Authorization for use of Pfizer-BioNTech (BNT-162b2) coronavirus disease 2019 vaccine to include people ages 12 years and older on...
7.
Cortese M, Taylor A, Akinbami L, Thames-Allen A, Yousaf A, Campbell A, et al.
J Infect Dis . 2023 Feb; 228(2):143-148. PMID: 36821777
Multisystem inflammatory syndrome in children (MIS-C) is a complication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection; in the United States, reporting of MIS-C after coronavirus disease 2019 (COVID-19)...
8.
Wang X, Velasquez Portocarrero D, Cortese M, Parashar U, Zaman K, Jiang B
Hum Vaccin Immunother . 2023 Jan; 19(1):2167437. PMID: 36715015
In a clinical trial of Bangladeshi infants who received three doses of RotaTeq (ages 6, 10, and 14 weeks), we did a head-to-head assessment of two vaccine virus strains to...
9.
Kracalik I, Oster M, Broder K, Cortese M, Glover M, Shields K, et al.
Lancet Child Adolesc Health . 2022 Sep; 6(11):788-798. PMID: 36152650
Background: Data on medium-term outcomes in indivduals with myocarditis after mRNA COVID-19 vaccination are scarce. We aimed to assess clinical outcomes and quality of life at least 90 days since...
10.
Mijatovic-Rustempasic S, Jaimes J, Perkins C, Ward M, Esona M, Gautam R, et al.
Viruses . 2022 Aug; 14(8). PMID: 36016397
Before the introduction of vaccines, group A rotaviruses (RVA) were the leading cause of acute gastroenteritis in children worldwide. The National Rotavirus Strain Surveillance System (NRSSS) was established in 1996...